D31.50
Benign neoplasm of unspecified lacrimal gland and duct
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign neoplasm of the lacrimal gland and duct is a non-cancerous growth that develops in the tissues responsible for producing tears and facilitating their flow toward the surface of the eye. This condition can occur anywhere within the lacrimal gland or its associated ducts, leading to potential symptoms related to eye comfort and appearance. Although labeled as benign, understanding this condition can assist in managing eye health effectively and recognizing when medical evaluation is necessary.
Causes & Symptoms
Clinical Causes: Unknown exact cause, but hereditary factors may play a role. Genetic mutations leading to abnormal cell growth in the lacrimal tissue. Chronic inflammation or irritation of the lacrimal gland. Environmental exposures or occupational hazards that impact eye tissues. Previous ocular trauma or surgeries may contribute to abnormal tissue changes.
Key Symptoms: Painless swelling or lump near the outer corner of the eye. A noticeable mass in the area of the lacrimal gland. Possible mild discomfort or a feeling of fullness around the eye. Less commonly, symptoms may include tearing abnormalities or dry eye sensations.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist, who might observe a palpable or visible mass in the lacrimal area. Imaging studies such as ultrasound, CT scans, or MRI may be used to determine the size and extent of the growth. In some cases, a biopsy might be performed to confirm the benign nature of the neoplasm and rule out malignancy. Additional tests for tears and gland function may also be employed to assess any impact on eye health.
Treatment Protocols: Treatment options depend on the size, location, and symptoms caused by the growth. Common approaches include: - Observation: Small, asymptomatic benign neoplasms may be monitored regularly without immediate intervention. - Surgical removal: For larger or symptomatic growths, careful excision of the tumor might be performed to alleviate discomfort and prevent complications. - Postoperative care may involve managing inflammation or infection risk, and regular follow-up to monitor for recurrence. In rare cases, if the tumor recurs or causes significant issues, further surgical or medical interventions might be necessary.
Clinical Advice & FAQs
Billing Guidance
Is D31.50 a billable ICD-10 code?
Yes, D31.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D31.50?
Clinical documentation must specify the nature of Benign neoplasm of unspecified lacrimal gland and duct and any associated comorbidities for accurate reporting.
Cite this Clinical Reference